Advanced Colorectal Cancer, KRAS Testing

See Cepmed’s Personalized Medicine Portal for more information about this test

Read More

Select your province to learn about access to testing & services in your area.

Overview

If you have advanced colon cancer and are considering an EGFR-targeted therapy, like Erbitux® (cetuximab) or Vectibix® (panitumumab), you may benefit from KRAS testing. KRAS testing can help predict whether these drugs will work for you. Follow the Read More button above to learn more.

Testing may be available through a public laboratory in your province, or in another province or through a private laboratory. For patients eligible to receive cetuximab or panitumumab KRAS testing is often paid for by the drug manufacturer. Amgen is the Canadian manufacturer of Vectibix and Bristol-Myers Squibb the Canadian manufacturer of Erbitux. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Laboratories

Overview

If you have advanced colon cancer and are considering an EGFR-targeted therapy, like Erbitux® (cetuximab) or Vectibix® (panitumumab), you may benefit from KRAS testing. KRAS testing can help predict whether these drugs will work for you. Follow the Read More button above to learn more.

Testing may be available through a public laboratory in your province, or in another province or through a private laboratory. For patients eligible to receive cetuximab or panitumumab KRAS testing is often paid for by the drug manufacturer. Amgen is the Canadian manufacturer of Vectibix and Bristol-Myers Squibb the Canadian manufacturer of Erbitux. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Laboratories

Overview

If you have advanced colon cancer and are considering an EGFR-targeted therapy, like Erbitux® (cetuximab) or Vectibix® (panitumumab), you may benefit from KRAS testing. KRAS testing can help predict whether these drugs will work for you. Follow the Read More button above to learn more.

Testing may be available through a public laboratory in your province, or in another province or through a private laboratory. For patients eligible to receive cetuximab or panitumumab KRAS testing is often paid for by the drug manufacturer. Amgen is the Canadian manufacturer of Vectibix and Bristol-Myers Squibb the Canadian manufacturer of Erbitux. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Providers

Overview

If you have advanced colon cancer and are considering an EGFR-targeted therapy, like Erbitux® (cetuximab) or Vectibix® (panitumumab), you may benefit from KRAS testing. KRAS testing can help predict whether these drugs will work for you. Follow the Read More button above to learn more.

Testing may be available through a public laboratory in your province, or in another province or through a private laboratory. For patients eligible to receive cetuximab or panitumumab KRAS testing is often paid for by the drug manufacturer. Amgen is the Canadian manufacturer of Vectibix and Bristol-Myers Squibb the Canadian manufacturer of Erbitux. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Laboratories

Overview

If you have advanced colon cancer and are considering an EGFR-targeted therapy, like Erbitux® (cetuximab) or Vectibix® (panitumumab), you may benefit from KRAS testing. KRAS testing can help predict whether these drugs will work for you. Follow the Read More button above to learn more.

Testing may be available through a public laboratory in your province, or in another province or through a private laboratory. For patients eligible to receive cetuximab or panitumumab KRAS testing is often paid for by the drug manufacturer. Amgen is the Canadian manufacturer of Vectibix and Bristol-Myers Squibb the Canadian manufacturer of Erbitux. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Laboratories

Overview

If you have advanced colon cancer and are considering an EGFR-targeted therapy, like Erbitux® (cetuximab) or Vectibix® (panitumumab), you may benefit from KRAS testing. KRAS testing can help predict whether these drugs will work for you. Follow the Read More button above to learn more.

Testing may be available through a public laboratory in your province, or in another province or through a private laboratory. For patients eligible to receive cetuximab or panitumumab KRAS testing is often paid for by the drug manufacturer. Amgen is the Canadian manufacturer of Vectibix and Bristol-Myers Squibb the Canadian manufacturer of Erbitux. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Laboratories

Overview

If you have advanced colon cancer and are considering an EGFR-targeted therapy, like Erbitux® (cetuximab) or Vectibix® (panitumumab), you may benefit from KRAS testing. KRAS testing can help predict whether these drugs will work for you. Follow the Read More button above to learn more.

Testing may be available through a public laboratory in your province, or in another province or through a private laboratory. For patients eligible to receive cetuximab or panitumumab KRAS testing is often paid for by the drug manufacturer. Amgen is the Canadian manufacturer of Vectibix and Bristol-Myers Squibb the Canadian manufacturer of Erbitux. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Laboratories

Overview

If you have advanced colon cancer and are considering an EGFR-targeted therapy, like Erbitux® (cetuximab) or Vectibix® (panitumumab), you may benefit from KRAS testing. KRAS testing can help predict whether these drugs will work for you. Follow the Read More button above to learn more.

Testing may be available through a public laboratory in your province, or in another province or through a private laboratory. For patients eligible to receive cetuximab or panitumumab KRAS testing is often paid for by the drug manufacturer. Amgen is the Canadian manufacturer of Vectibix and Bristol-Myers Squibb the Canadian manufacturer of Erbitux. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Laboratories

Overview

If you have advanced colon cancer and are considering an EGFR-targeted therapy, like Erbitux® (cetuximab) or Vectibix® (panitumumab), you may benefit from KRAS testing. KRAS testing can help predict whether these drugs will work for you. Follow the Read More button above to learn more.

Testing may be available through a public laboratory in your province, or in another province or through a private laboratory. For patients eligible to receive cetuximab or panitumumab KRAS testing is often paid for by the drug manufacturer. Amgen is the Canadian manufacturer of Vectibix and Bristol-Myers Squibb the Canadian manufacturer of Erbitux. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Laboratories

Overview

If you have advanced colon cancer and are considering an EGFR-targeted therapy, like Erbitux® (cetuximab) or Vectibix® (panitumumab), you may benefit from KRAS testing. KRAS testing can help predict whether these drugs will work for you. Follow the Read More button above to learn more.

Testing may be available through a public laboratory in your province, or in another province or through a private laboratory. For patients eligible to receive cetuximab or panitumumab KRAS testing is often paid for by the drug manufacturer. Amgen is the Canadian manufacturer of Vectibix and Bristol-Myers Squibb the Canadian manufacturer of Erbitux. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Laboratories